Search results for: 'ai infrastructure development access adas'
- Did you mean
- ai infrastructure development access a9aa
- Related search terms
- development startup and future trend of ophthalmic drugs market
- development states and future trend of ophthalmic drugs market
- development startup ad future trend of ophthalmic drugs market
- adas pacific managed security services market forecast to 2014
- adas ar market
-
17 Oct 2025  |  Global  |  Technology Research
Recent Advances in Biologics and AI-based Drug Discovery and Development
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides actionable insights across new developments in prebiotics, immunology, oncology, cell and gene therapies, antibody therapies, and precision medicine approaches. The TOE also encompasses technology advances across the use of AI and ML in drug discovery a...
$950.00 -
01 Jun 2026  |  Global  |  Market Research
Biopharma Patient Access Market, Global, 2026
Access-Controlled Commercialization is Experiencing Transformational Growth due to Rising Specialty Therapy Complexity
The global biopharma patient access market is undergoing a structural shift as specialty medicines make downstream commercialization more complex and strategically important. Patient access is no longer limited to reimbursement support or hub services; it is becoming a commercialization control layer spanning authorization, affordability, therapy i...
$2,450.00 -
06 Dec 2023  |  North America  |  Technology Research
Growth Opportunities of Generative AI For Healthcare
Emerging Applications in Drug Discovery and Development, Medical Imaging Analysis, Digital Twins, Synthetic Data, Electronic Health Record Management, and Virtual Assistants
The application of Generative AI (Gen AI) in healthcare is a rapidly growing field. In recent years, emerging applications in drug discovery and development, medical imaging analysis, digital twins, synthetic data, and electronic health records management, and virtual assistants have garnered significant interest thanks to their potential to revolu...
$4,950.00
Special Price $3,712.50 save 25 %
-
12 Dec 2025  |  Global  |  Frost Radar
Frost Radar: AI-Enabled Drug Discovery, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
The discovery of new drug targets for diseases with unmet medical needs has long been hindered by the complexity of processing and interpreting massive volumes of biological data. The increasing volume and veracity of clinical and research data compels the use of enabling tools and technologies, such as cloud computing, AI, machine learning, natura...
$4,950.00 -
07 Mar 2023  |  Global  |  Market Research
Conversational AI in Healthcare
The Utility of Chatbots and Voice AI Is Poised for Rapid Acceleration
The impact of the digital revolution continues to disrupt the healthcare industry. This includes evolving digital technological capabilities, new business models and marketing approaches, the healthcare consumerism trend, the changing regulatory environment, and competitive threats from new market entrants, such as digital-native companies—particul...
$4,950.00
Special Price $3,712.50 save 25 %
-
13 Dec 2021  |  Global  |  Technology Research
Technology Enablers Facilitating Microbiome Adoption in Research and Development
Advancements in Analytical Methods and Digital Tools Fuel Growth Opportunities in Microbiome Research and Product Development
Microbiome research is on the rise following technological advancements and significant cost reductions in microbiome analysis. Research has unlocked the potential of microbiome in medical use cases, yielding tremendous insights on its nature, interactions, and impact within a host and in an external environment. Advanced studies on the role of mic...
$4,950.00
Special Price $3,712.50 save 25 %
-
01 Feb 2022  |  Global  |  Frost Radar
Frost Radar™: Global Enterprise Health Cloud Infrastructure and Platform Services, 2021
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
The COVID-19 pandemic has revealed that many healthcare organizations have neither the agility and business continuity programs nor the technologies needed to support them during a crisis. Consequently, some have been forced to act on cloud and digital transformation strategies they had been delaying. The cloud has been critical in helping healthca...
$4,950.00
Special Price $3,712.50 save 25 %
-
07 Sep 2026  |  Global  |  Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Technology Advancements, Clinical Progress, and Growth Opportunities in AI-Enabled Antibody Therapeutics
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion models, and structure-based models are expanding the u...
$4,950.00 -
04 Mar 2026  |  Global  |  Market Research
Growth Opportunities in Conversational AI in Healthcare, Global, 2025–2030
Conversational AI and Agentic AI Across Clinical and Non-clinical Workflows are Driving Transformational Growth
Conversational AI solutions are designed to enhance communication and coordination among healthcare stakeholders. These voice and text applications automate human information gathering and communications and represent a growing opportunity for healthcare organizations to improve clinician efficiency, operational and administrative efficiency, healt...
$4,950.00 -
20 Feb 2024  |  North America  |  Market Research
Growth Opportunities in Drug Discovery and Early Development Outsourcing Services
M&As, Partnerships, and the Shift Toward an End-to-end CRDMO Model will Boost Sector Expansion
The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....
$4,950.00
Special Price $3,712.50 save 25 %